http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP11011099-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
filingDate 2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bd98e1dfe6762f38f7af4f36e50edae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce5cef8d194330ff2f8ff66db6c40281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0adc9c9f78b1f5ce5c89ef2010510711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de97db40474041fdf29ee6b12a6c56d5
publicationDate 2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP11011099-A
titleOfInvention AGONIST PEPTIDES OF CRHR2 AND USES OF THESE
abstract The present invention relates to novel peptides that are selective agonists of the type 2 corticotropin release hormone receptor (CRHR2) and their compositions for the treatment, improvement or inhibition of cardiovascular conditions that include, but are not limited to, the heart failure. The novel agonist peptide preferably comprises modifications that include pegylated peptides. In addition, the present invention relates to methods for the treatment and prevention of a disease or disorder related to the activity of CRHR2.
priorityDate 2008-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12922
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100002312
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID380532
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581612
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1395
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132265
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID521831
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64680

Total number of triples: 36.